Cargando…

N-(2-Meth­oxy­benz­yl)-9-(oxolan-2-yl)-9H-purin-6-amine

The title compound, C(17)H(19)N(5)O(2), features an almost planar purine skeleton (r.m.s. deviation = 0.009 Å) substituted by a tetra­hydro­furan ring, which adopts an envelope conformation. The purine and benzene rings subtend a dihedral angle of 66.70 (3)°. In the crystal, pairs of N—H⋯N hydrogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Trávníček, Zdeněk, Popa, Igor, Dvořák, Zdeněk, Štarha, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629632/
https://www.ncbi.nlm.nih.gov/pubmed/23634119
http://dx.doi.org/10.1107/S1600536813007721
Descripción
Sumario:The title compound, C(17)H(19)N(5)O(2), features an almost planar purine skeleton (r.m.s. deviation = 0.009 Å) substituted by a tetra­hydro­furan ring, which adopts an envelope conformation. The purine and benzene rings subtend a dihedral angle of 66.70 (3)°. In the crystal, pairs of N—H⋯N hydrogen bonds connect adjacent mol­ecules into inversion dimers. C—H⋯N, C—H⋯O, C—H⋯π and π–π inter­actions [pyrimidine ring centroid–centroid distance = 3.3909 (1) Å] connect the dimers into a three-dimensional architecture.